Zheshang Securities(SH:601878) Xin Lang Cai Jing·2025-09-15 06:45Core Viewpoint - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. experienced a 5.02% drop in stock price, closing at 38.43 CNY per share, with a trading volume of 1.195 billion CNY and a turnover rate of 6.71%, resulting in a total market capitalization of 18.361 billion CNY [1] Company Overview - Shuyou Shen was established on August 16, 2002, and went public on April 15, 2011. The company is primarily engaged in the research, development, production, and sales of biological products and some chemical drugs [1] - The main revenue sources are: 59.17% from injectable mouse nerve growth factor (Sutai Sheng), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1] Fund Holdings - Zhejiang Merchants Securities Asset Management has a fund that heavily invests in Shuyou Shen. The fund, Zhejiang Merchants Huijin Quantitative Selected Mixed Fund (006449), held 143,900 shares in the second quarter, accounting for 5.18% of the fund's net value, making it the second-largest holding [2] - The fund has a current scale of 104 million CNY and has achieved a return of 65.21% this year, ranking 376 out of 8,246 in its category. Over the past year, it has returned 95.51%, ranking 580 out of 8,054 [2] Fund Manager Information - The fund manager of Zhejiang Merchants Huijin Quantitative Selected Mixed Fund is Pang Yaqing, who has been in the position for 1 year and 231 days. The fund's total asset size is 104 million CNY, with the best and worst returns during the tenure both recorded at 75.13% [3]